Guidance needs review for AMZN (2026-04-09 - stale), ORCL (2026-03-10 - stale). Events older than one earnings cycle must not be read as current guidance.
$130-$145B
We anticipate 2026 capital expenditures, including principal payments on finance leases, to be in the range of $130-145 billion, narrowed from our prior outlook of $125-145 billion.
2026-07-29 - freshRule-based
$180-$190B
$180-$190 billion, and that it expects 2027 capital expenditures to significantly increase compared to 2026.
2026-06-04 - freshRule-based
Qualitative guidance
$180-$190 billion, and that it expects 2027 capital expenditures to significantly increase compared to 2026.
2026-06-04 - freshRule-based
$125-$145B
We anticipate 2026 capital expenditures, including principal payments on finance leases, to be in the range of $125-145 billion, increased from our prior range of $115-135 billion.
2026-04-29 - agingRule-based
$190B
We expect to remain constrained at least through 2026.
2026-04-29 - agingRule-based
$200B
We're not investing approximately $200 billion in capex in 2026 on a hunch.
2026-04-09 - staleRule-based
$50B
For fiscal year 2026, we expect revenue of $67 billion and capital expenditures of $50 billion.
2026-03-10 - staleRule-based
$115-$135B
We anticipate 2026 capital expenditures, including principal payments on finance leases, to be in the range of $115-135 billion, with year-over-year growth driven by increased investment to support our Meta Superintelligence Labs efforts and core business.
2026-01-28 - staleRule-based